Tango Therapeutics, Inc. Income Tax Expense
Tango Therapeutics, Inc. (TNGX) reported Income Tax Expense of $1.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxExpenseBenefit · last filed 2026-08-11
- Tango Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2026-06-30 was $1.00K, a 97.14% decline year-over-year.
- Tango Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2026-03-31 was $1.00K, a 97.06% decline year-over-year.
- Tango Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2025-12-31 was -$55.00K, a 212.24% decline year-over-year.
- Tango Therapeutics, Inc. income tax expense (benefit) for the quarter ending 2025-09-30 was -$10.00K, a 118.52% decline year-over-year.
- Tango Therapeutics, Inc. income tax expense (benefit) for fiscal 2025 was $4.00K, a 98.08% decline from fiscal 2024.
- Tango Therapeutics, Inc. income tax expense (benefit) for fiscal 2024 was $208.00K, a 55.22% increase from fiscal 2023.
- Tango Therapeutics, Inc. income tax expense (benefit) for fiscal 2023 was $134.00K, a 148.15% increase from fiscal 2022.
- Tango Therapeutics, Inc. income tax expense (benefit) for fiscal 2022 was $54.00K, a 81.51% decline from fiscal 2021.
| Period end | Income Tax Expense (Benefit) 3 month | Income Tax Expense (Benefit) 3 month as first filed | Income Tax Expense (Benefit) 6 month | Income Tax Expense (Benefit) 6 month as first filed | Income Tax Expense (Benefit) 7 month | Income Tax Expense (Benefit) 9 month | Income Tax Expense (Benefit) 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.00K 10-Q · filed 2026-08-11 | $2.00K 10-Q · filed 2026-08-11 | -$53.00K derived: sum of 3 quarters · filed 2026-08-11 | -$63.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2026-03-31 | $1.00K 10-Q · filed 2026-05-13 | -$54.00K derived: sum of 2 quarters · filed 2026-05-13 | -$64.00K derived: sum of 3 quarters · filed 2026-05-13 | -$29.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-12-31 | -$55.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | -$65.00K derived: sum of 2 quarters · filed 2026-03-05 | -$30.00K derived: sum of 3 quarters · filed 2026-08-11 | $4.00K 10-K · filed 2026-03-05 | |||
| 2025-09-30 | -$10.00K 10-Q · filed 2025-11-04 | $25.00K derived: sum of 2 quarters · filed 2026-08-11 | $59.00K 10-Q · filed 2025-11-04 | $108.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-06-30 | $35.00K 10-Q · filed 2026-08-11 | $69.00K 10-Q · filed 2026-08-11 | $118.00K derived: sum of 3 quarters · filed 2026-08-11 | $172.00K derived: sum of 4 quarters · filed 2026-08-11 | |||
| 2025-03-31 | $34.00K 10-Q · filed 2026-05-13 | $83.00K derived: sum of 2 quarters · filed 2026-05-13 | $137.00K derived: sum of 3 quarters · filed 2026-05-13 | $202.00K derived: sum of 4 quarters · filed 2026-05-13 | |||
| 2024-12-31 | $49.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $103.00K derived: sum of 2 quarters · filed 2026-03-05 | $168.00K derived: sum of 3 quarters · filed 2026-03-05 | $208.00K 10-K · filed 2026-03-05 | |||
| 2024-09-30 | $54.00K 10-Q · filed 2025-11-04 | $119.00K derived: sum of 2 quarters · filed 2025-11-04 | $159.00K 10-Q · filed 2025-11-04 | $206.00K derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-06-30 | $65.00K 10-Q · filed 2025-08-05 | $105.00K 10-Q · filed 2025-08-05 | $152.00K derived: sum of 3 quarters · filed 2026-03-05 | $175.00K derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2024-03-31 | $40.00K 10-Q · filed 2025-05-12 | $87.00K derived: sum of 2 quarters · filed 2026-03-05 | $110.00K derived: sum of 3 quarters · filed 2026-03-05 | $174.00K derived: sum of 4 quarters · filed 2026-03-05 | |||
| 2023-12-31 | $47.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $70.00K derived: sum of 2 quarters · filed 2026-03-05 | $134.00K derived: sum of 3 quarters · filed 2026-03-05 | $134.00K 10-K · filed 2026-03-05 | |||
| 2023-09-30 | $23.00K 10-Q · filed 2024-11-06 | $87.00K derived: sum of 2 quarters · filed 2024-11-06 | $87.00K 10-Q · filed 2024-11-06 | $138.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-06-30 | $64.00K 10-Q · filed 2024-08-07 | $64.00K 10-Q · filed 2024-08-07 | $115.00K derived: sum of 3 quarters · filed 2025-02-27 | $115.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2023-03-31 | $0.00 10-Q · filed 2024-05-08 | $51.00K derived: sum of 2 quarters · filed 2025-02-27 | $51.00K derived: sum of 3 quarters · filed 2025-02-27 | $54.00K derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $51.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $51.00K derived: sum of 2 quarters · filed 2025-02-27 | $54.00K derived: sum of 3 quarters · filed 2025-02-27 | $54.00K 10-K · filed 2025-02-27 | |||
| 2022-09-30 | $0.00 10-Q · filed 2023-11-08 | $3.00K derived: sum of 2 quarters · filed 2023-11-08 | $3.00K 10-Q · filed 2023-11-08 | $180.00K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $3.00K 10-Q · filed 2023-08-07 | $100.00K 10-Q · filed 2024-08-07 | $3.00K 10-Q · filed 2022-08-10 | $180.00K derived: sum of 3 quarters · filed 2023-08-07 | $242.00K derived: sum of 4 quarters · filed 2023-08-07 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-09 | $177.00K derived: sum of 2 quarters · filed 2023-05-09 | $239.00K derived: sum of 3 quarters · filed 2023-05-09 | $218.00K derived: sum of 4 quarters · filed 2023-05-09 | |||
| 2021-12-31 | $177.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-27 | $239.00K derived: sum of 2 quarters · filed 2023-03-27 | $218.00K derived: sum of 3 quarters · filed 2023-03-27 | $292.00K 10-K · filed 2023-03-27 | |||
| 2021-09-30 | $62.00K 10-Q · filed 2022-11-10 | $41.00K derived: sum of 2 quarters · filed 2022-11-10 | $115.00K 10-Q · filed 2022-11-10 | $115.00K derived: sum of 4 quarters · filed 2022-11-10 | |||
| 2021-06-30 | -$21.00K 10-Q · filed 2022-08-10 | $53.00K 10-Q · filed 2022-08-10 | $525.00 10-Q · filed 2021-08-09 | $53.00K derived: sum of 3 quarters · filed 2022-08-10 | $53.00K derived: sum of 4 quarters · filed 2022-08-10 | ||
| 2021-03-31 | $74.00K 10-Q · filed 2022-05-11 | $525.00 10-Q · filed 2021-05-14 | $74.00K derived: sum of 2 quarters · filed 2022-05-11 | $74.00K derived: sum of 3 quarters · filed 2022-05-11 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $0.00 derived: sum of 2 quarters · filed 2022-03-28 | $6.86K 10-K · filed 2021-03-31 | $0.00 10-K · filed 2022-03-28 | |||
| 2020-09-30 | $0.00 10-Q · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Indivior Pharmaceuticals, Inc. (INDV) | $4.250B | 14.09 | |
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Veradermics, Inc (MANE) | United States | $4.839B | |
| Amylyx Pharmaceuticals, Inc. (AMLX) | United States | $3.361B | -13.15 |